成都静脉曲张手术费用明细(成都哪些方法可以治疗脉管炎) (今日更新中)

WASHINGTON, July 12 (Xinhua) -- Two U.S. astronauts stepped out the International Space Station on Tuesday to retrieve a failed ammonia pump, which is the last spacewalk of the shuttle era, NASA announced.Space station astronauts Mike Fossum and Ron Garan completed the six-hour, 31-minute spacewalk at 3:53 p.m. EDT (1953 GMT). The duo retrieved a pump module from an external stowage platform on station and store it in shuttle Atlantis' cargo bay for return to Earth.The pump module failed in 2010, shutting down half of the space station's cooling system. Engineers will evaluate the module to determine the cause of the failure and plan to refurbish it for use as a spare.The astronauts also attached a Robotic Refueling Module experiment to the space station, which aims to test technologies for repairing and refueling satellites in space.It was the 249th spacewalk by U.S. astronauts and the 160th spacewalk in support of space station assembly and maintenance, totaling 1009 hours, nine minutes.Atlantis lifted off on Friday morning from Kennedy Space Center in Florida, on the 135th and final flight in NASA's shuttle program. Its return to the earth later this month will mark the end of the 30-year shuttle program.

New York, Sept. 23 (Xinhua) -- A Chinese scientist was presented a prestigious U.S. award on Friday for the discovery of artemisinin, a drug therapy for malaria that has saved millions of lives across the globe, especially in the developing world.Pharmacologist Tu Youyou, 81, became the first scientist on the Chinese mainland to win Lasker Award, known as "America's Nobels" for their knack of gaining future recognition by the Nobel committee.Tu, a scientist at the China Academy of Chinese Medical Sciences in Beijing, pioneered a new approach to malaria treatment that has benefited hundreds of millions of people and promises to benefit many times more. By applying modern techniques and rigor to a heritage provided by 5000 years of Chinese traditional practitioners, she has delivered its riches into the 21st century."Not often in the history of clinical medicine can we celebrate a discovery that has eased the pain and distress of hundreds of millions of people and saved the lives of countless numbers of people, particularly children, in over 100 countries," Lucy Shapiro, a member of the award jury and professor of Stanford University, said while describing Tu' s discovery.Shapiro said the discovery, chemical identification, and validation of artemisinin, a highly effective anti-malarial drug, is largely due to the "scientific insight, vision and dogged determination" of Professor Tu and her team. She thought Professor Tu's work has provided the world with arguably the most important pharmaceutical intervention in the last half century."The discovery of artemisinin is a gift to mankind from traditional Chinese medicine," Tu said while receiving the award. "Continuous exploration and development of traditional medicine will, without doubt, bring more medicines to the world."

BEIJING, July 26 (Xinhuanet) -- Seven of the 20 top selling American prescription drugs will lose their patents by the end of next year, making way for less expensive generic versions, according to media reports.It's a shift that could save consumers billions of dollars -- assuming those big-ticket medications are willing to give up a trusted brand name for an off-label replacement.The prices of medications such as cholesterol-fighting Lipitor and blood thinner Plavix are expected to go down significantly, according to the U.S. Food and Drug Administration (FDA).Lipitor will lose its patent in November. When that patent expires, people are advised to buy atorvastatin, the generic equivalent. Other brand names include the anti-psychotic Zyprexa and the rheumatoid arthritis and psoriasis drug Enbrel, of which the patent will expire in October and October of next year, respectively.Over the next 10 years, an estimated 120 more brand-name prescription drugs will lose their patents in the U.S.

XICHANG, Sichuan, July 27 (Xinhua)-- China successfully launched an orbiter into space at 5:44 a.m. Beijing Time Wednesday, as a part of its indigenous satellite navigation and positioning network known as Beidou, or Compass system, sources with the launch center said.The orbiter,launched from the Xichang Satellite Launch Center in southwestern Sichuan Province, was boosted by a Long March-3A carrier rocket into a geostationary orbit.China started to build up its own satellite navigation system to break its dependence on the U.S. Global Positioning System (GPS) in 2000.A Long March-3A carrier rocket lifts off at the Xichang Satellite Launch Center in southwest China's Sichuan Province, July 27, 2011. China successfully launched into space a ninth orbiter for its independent satellite navigation and positioning network known as Beidou, or Compass System here early WednesdayBetween October 2000 and May 2003, the country set up a regional satellite navigation system after launching three Beidou geostationary satellites.The system was known as Beidou-1 and is said to have played an important role in the rescue efforts following the devastating earthquake in May 2008 in Wenchuan as it provided the only channel connecting the quake-hit area and the outside.The Beidou-1 system can not meet growing demand, so a better functional Beidou-2 regional and global navigation system will be set up, Qi Faren, former chief designer for Shenzhou spaceships said in an interview with Xinhua early this year.From April 2007 to April this year, China launched another eight orbiters to form its Beidou-2 system, which will eventually consist of 35 satellites.The network will provide satellite navigation, time and short message services for Asia-Pacific regions by 2012 and global services by 2020.

来源：资阳报